GDRX
Goodrx Holdings Inc
NASDAQ: GDRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$2.36
+3.06% today
Updated 2026-04-30
Market cap
$781.07M
P/E ratio
25.33
P/S ratio
0.98x
EPS (TTM)
$0.09
Dividend yield
—
52W range
$2 – $6
Volume
2.4M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
2.7
Growth
F6.0
Quality
B5.5
Profitability
C+5.3
Valuation
C+5/9
Piotroski F-Score
Moderate
0.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$2.82
+19.28%
12-Month target
$1.84
-22.03%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy4 Buy8 Hold0 Sell2 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $31.65M — positive
Risks
- Altman Z 0.47 — distress zone
- Thin margins at 3.82%
- Revenue declining -1.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $766.55M | $750.26M | $792.32M | $796.85M | $796.85M |
| Net income | $-32.83M | $-8.87M | $16.39M | $30.44M | $5.42M |
| EPS | — | — | — | — | $0.09 |
| Free cash flow | $91.57M | $82.53M | $113.55M | $164.38M | $31.65M |
| Profit margin | -4.28% | -1.18% | 2.07% | 3.82% | 3.82% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | MCGINNIS, CHRISTOPHER A | Sale | 36,987 | — |
| 2026-04-15 | MCGINNIS, CHRISTOPHER A | Buy | 36,987 | — |
| 2026-04-15 | MCGINNIS, CHRISTOPHER A | Sale | 10,745 | $2.23 |
Peer comparison
Smart narrative
Goodrx Holdings Inc trades at $2.36. representing a P/E of 25.33x trailing earnings. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 0.47, it sits in the distress. TTM revenue stands at $796.85M. with profit margins at 3.82%.
Frequently asked questions
What is Goodrx Holdings Inc's stock price?
Goodrx Holdings Inc (GDRX) trades at $2.36.
Is Goodrx Holdings Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell).
What is the price target of Goodrx Holdings Inc (GDRX)?
The analyst target price is $2.82, representing +19.3% upside from the current price of $2.36.
What is the future stock price of GDRX by 2030?
Our revenue-driven model estimates Goodrx Holdings Inc could reach $8.54 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Goodrx Holdings Inc's revenue?
TTM revenue is $796.85M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
0.47 — distress.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.98x
ROE4.54%
Beta1.47
50D MA$2.20
200D MA$3.20
Shares out0.11B
Float0.10B
Short ratio—
Avg volume2.4M
Performance
1 week-0.43%
1 month+16.84%
3 months-4.58%
YTD-15.50%
1 year—
3 years—
5 years—